VolitionRX LimitedVolitionRX LimitedVolitionRX Limited

VolitionRX Limited

No trades
See on Supercharts
Market capitalization
‪50.55 M‬USD
‪−35.32 M‬USD
‪775.30 K‬USD
‪60.56 M‬
Beta (1Y)

About VolitionRX Limited

Cameron John Reynolds
Employees (FY)
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VNRX is 0.6160 USD — it has decreased by 0.19% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange VolitionRX Limited stocks are traded under the ticker VNRX.
VolitionRX Limited is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
VNRX stock is 14.04% volatile and has beta coefficient of 0.50. Check out the list of the most volatile stocks — is VolitionRX Limited there?
One year price forecast for VolitionRX Limited has a max estimate of 4.5000 USD and a min estimate of 2.5000 USD.
VNRX earnings for the last quarter are −0.11 USD per share, whereas the estimation was −0.13 USD resulting in a 14.06% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about VolitionRX Limited earnings.
VolitionRX Limited revenue for the last quarter amounts to ‪165.21 K‬ USD despite the estimated figure of ‪356.60 K‬ USD. In the next quarter revenue is expected to reach ‪466.67 K‬ USD.
Yes, you can track VolitionRX Limited financials in yearly and quarterly reports right on TradingView.
VNRX stock has fallen by 13.24% compared to the previous week, the month change is a 28.37% fall, over the last year VolitionRX Limited has showed a 60.76% decrease.
VNRX net income for the last quarter is ‪−8.70 M‬ USD, while the quarter before that showed ‪−8.37 M‬ USD of net income which accounts for −3.92% change. Track more VolitionRX Limited financial stats to get the full picture.
Today VolitionRX Limited has the market capitalization of ‪50.55 M‬, it has decreased by 5.81% over the last week.
No, VNRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VNRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VolitionRX Limited stock right from TradingView charts — choose your broker and connect to your account.
VNRX reached its all-time high on Sep 22, 2014 with the price of 9.2799 USD, and its all-time low was 0.2500 USD and was reached on May 9, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 110.00 employees. See our rating of the largest employees — is VolitionRX Limited on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VolitionRX Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VolitionRX Limited stock shows the sell signal. See more of VolitionRX Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VolitionRX Limited future price: according to them, VNRX price has a max estimate of 4.50 USD and a min estimate of 2.50 USD. Read a more detailed VolitionRX Limited forecast: see what analysts think of VolitionRX Limited and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VolitionRX Limited EBITDA is ‪−34.58 M‬ USD, and current EBITDA margin is ‪−4.46 K‬%. See more stats in VolitionRX Limited financial statements.